SCOTUS declines to review former Insys founder John Kapoor`s conviction
13 Jun 2022 //
ENDPTS
Ex-Insys execs owe nearly $50M in opioid restitution
30 Nov 2021 //
FIERCEPHARMA
National Comprehensive Cancer Network® Adds Monjuvi® (tafasitamab-cxix)
18 Aug 2020 //
BUSINESSWIRE
Ex-Insys Sales Rep Evades Prison Over Opioid Bribe Ploy
17 Aug 2020 //
LAW360
Insys Execs Can`t Dodge Prison During Appeal, Seek Delay
02 Jul 2020 //
WWW.LAW360
Opioid executive admits to ‘no morals’ ahead of prison term
24 Jan 2020 //
FINANCIAL TIMES
Former Insys exec decries sexist hiring in sentencing memo
23 Jan 2020 //
FIERCE PHARMA
Opioid-Maker Insys Wins Court Approval of Bankruptcy Plan
17 Jan 2020 //
WSJ
Former Insys VP tagged with 33-month sentence in Subsys kickback scheme
15 Jan 2020 //
FIERCE PHARMA
Federal judge overturns part of Insys founder Kapoor`s racketeering conviction
29 Nov 2019 //
FIERCE PHARMA
Bankrupt Insys offers to turn out its almost empty pockets for plaintiffs
23 Nov 2019 //
FIERCE PHARMA
Facing $4B in claims, Insys doubts ability to pay out via Chapter 11
21 Sep 2019 //
BIOPHARMADIVE
Bankrupt Insys cleared to sell opioid spray Subsys in $20M deal
21 Sep 2019 //
FIERCE PHARMA
Drugmaker Insys wins bankruptcy court approval to sell off opioid
19 Sep 2019 //
CNBC
Hikma picks up Insys naloxone spray in $12M bankruptcy buy
21 Aug 2019 //
FIERCE PHARMA
Hikma buys potential Epipen rival from troubled Insys
14 Aug 2019 //
PHARMAPHORUM
FDA rejects Kala`s dry eye drug; Troubled Insys finds a buyer in Hikma
10 Aug 2019 //
ENDPTS
States agree to pause lawsuits against bankrupt opioid maker Insys
02 Jul 2019 //
REUTERS
Pharma shells out $3B to doctors and hospitals—with Roche, Sanofi leading: CMS
02 Jul 2019 //
FIERCE PHARMA
Fate of opioid litigation hinges on government `police power`
26 Jun 2019 //
REUTERS
Insys files for bankruptcy on the heels of $225M kickback settlement
10 Jun 2019 //
FIERCE PHARMA
Insys, looking for a clean slate, agrees to pay $225M in Subsys kickback probe
06 Jun 2019 //
FIERCE PHARMA
Engulfed in legal trouble, bankruptcy answer for opioid drugmaker Insys
14 May 2019 //
ENDPTS
Insys founder, former execs face decades in jail after being found guilty
03 May 2019 //
ENDPTS
Insys`s founder, former executives found guilty criminal fentanyl bribery case
03 May 2019 //
CNBC
After 11 days, still no verdict in trial of former Insys drug executives
26 Apr 2019 //
STATNEWS
Insys Therapeutics names current CFO Andrew Long as company`s new CEO
16 Apr 2019 //
PHARMAFILE
Insys Replaces Its CEO as Opioid Past Weighs on Drugmaker
15 Apr 2019 //
BLOOMBERGQUINT
Former Insys VP to pay $9.5M in opioid spray kickback scheme
04 Apr 2019 //
FIERCE PHARMA
Insys Therapeutics Pushed Opioid With Bribes And Lies, Prosecutors Say
01 Apr 2019 //
NPR
Scandal-prone Subsys maker Insys falls as auditor flags going concern doubt
15 Mar 2019 //
ENDPTS
Insys Warns It Could Run out of Cash as It Continues to Face Litigation
14 Mar 2019 //
BIOSPACE
Insys says Lazard hired to advise on options, in talks to divest Subsys
08 Mar 2019 //
CNBC
Ex-Insys manager demands mistrial after topless photo testimony
05 Mar 2019 //
FIERCE PHARMA
Former sales exec says opioid maker Insys bribed doctors to prescribe drugs
04 Mar 2019 //
NBCNEWS
Insys Call Center Revealed at Trial as Hotbed of Opioid Lies
26 Feb 2019 //
BLOOMBERG
How the ‘Worst’ Launch in Pharma History Spurred Opioid Surge
13 Feb 2019 //
BLOOMBERG
How the ‘Worst’ Launch in Pharma History Spurred Opioid Surge
13 Feb 2019 //
BLOOMBERG
Insys executive gave doctor lap dance while promoting drug, witness says
30 Jan 2019 //
REUTERS
INSYS Therapeutics Announces Results of Dose-Finding PK Study for Epinephrine
09 Jan 2019 //
GLOBENEWSWIRE
Ex-Insys CEO to plead guilty to opioid kickback scheme
28 Dec 2018 //
REUTERS
Fentanyl Billionaire No More: John Kapoor`s Net Worth Drops Below $1B
07 Dec 2018 //
FORBES
Fentanyl : Insys Therapeutics vs. Teva Pharmaceutical
24 Nov 2018 //
PATENT LITIGATION
Yonsa (Abiraterone Acetate) : Sun Pharmaceutical vs. Teva Pharmaceuticals
19 Oct 2018 //
PATENT LITIGATION
Senzer`s inhaler delivers cannabinoids faster at lower doses
25 Sep 2018 //
BIOSPECTRUM
Fentanyl Sublingual Spray: Insys Therapeutics v. Teva Pharmaceutical Industries
24 Aug 2018 //
PATENT LITIGATION
Senator Grills FDA Over Handling of REMS for Transmucosal Fentanyl Products
22 Aug 2018 //
RAPS
Former Drug Co. exec Pleads Guilty In Fraud Scheme Costing Medicare Millions
10 Aug 2018 //
COURANT
FDA declines to approve Insys Therapeutic`s opioid painkiller
31 Jul 2018 //
REUTERS
FDA refuses to approve Insys opioid painkiller
30 Jul 2018 //
PHARMAPHORUM
Minnesota sues opioid maker Insys over improper drug marketing
30 May 2018 //
CNBC
Insys sees no change in estimated litigation costs
16 May 2018 //
REUTERS
INSYS & (UC) San Diego Center for Medicinal Cannabis Research to Collaborate
26 Apr 2018 //
GLOBENEWSWIRE
INSYS`s to Advance Clinical Research of Dronabinol Inhalation Using Novel Breath
18 Apr 2018 //
GLOBENEWSWIRE
Subsys® (Fentanyl ): Insys Therapeutics, Inc. v. Teva Pharmaceuticals USA
16 Mar 2018 //
PATENT LITIGATION
Doctor in Insys opioid kickback scheme gets four years in prison
09 Mar 2018 //
REUTERS
Opioid Maker Insys Still Has Fans - The pharmaceutical has lost top executives
06 Mar 2018 //
WALL STREET JOURNAL
INSYS Therapeutics Addresses New York Attorney General’s Complaint
01 Feb 2018 //
GLOBENEWSWIRE
INSYS Therapeutics Appoints Vaseem Mahboob to Board of Directors
01 Feb 2018 //
GLOBENEWSWIRE
INSYS Therapeutics Adds Two New Executives to Senior Management Team
30 Jan 2018 //
GLOBENEWSWIRE